Does monoclonal antibody treatment for COVID-19 impact short and long-term outcomes in a large generalisable population? A retrospective cohort study in the USA

Does monoclonal antibody treatment for COVID-19 impact short and long-term outcomes in a large generalisable population? A retrospective cohort study in the USA

Objectives To explore whether monoclonal antibodies (MAb) administered to high-risk patients with COVID-19 during the first week of illness prevent postacute sequelae of SARS-CoV-2 infection.Design Retrospective cohort study.Setting USA.Participants A sample of 3809 individuals who received MAbs and...

Full description

Bibliographic Details
Main Authors: Sarah E Daugherty, Yinglong Guo, Daniel Griffin, Chace McNeil, James Okusa, Diana Berrent
Format: Article
Language:English
Published: BMJ Publishing Group 2023-08-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/8/e069247.full

Internet

https://bmjopen.bmj.com/content/13/8/e069247.full

Similar Items